A business in context

BVS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-27 · 0001665988-26-000042

  2. 8-K · Current report

    Report date 2026-08-05 · 0001665988-26-000041 · Items 2.02,8.01,9.01

  3. 4 · Ownership change

    Report date 2026-06-02 · 0001904156-26-000004

  4. 4 · Ownership change

    Report date 2026-06-02 · 0001760737-26-000004

  5. 4 · Ownership change

    Report date 2026-06-02 · 0001679773-26-000006

  6. 8-K · Current report

    Report date 2026-06-03 · 0001665988-26-000035 · Items 5.07

  7. 4 · Ownership change

    Report date 2026-06-02 · 0001627985-26-000002

  8. 4 · Ownership change

    Report date 2026-06-02 · 0001382909-26-000001

  9. 4 · Ownership change

    Report date 2026-06-02 · 0001222362-26-000008

  10. 4 · Ownership change

    Report date 2026-06-02 · 0001221375-26-000002

  11. 4 · Ownership change

    Report date 2026-06-02 · 0001198330-26-000002

  12. 8-K · Current report

    Report date 2026-05-21 · 0001665988-26-000029 · Items 7.01

  13. 10-Q · Quarterly report

    Report date 2026-03-28 · 0001665988-26-000027

  14. 8-K · Current report

    Report date 2026-05-06 · 0001665988-26-000026 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001665988-26-000014

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001665988-26-000011

  17. 8-K · Current report

    Report date 2026-03-05 · 0001665988-26-000010 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2025-11-14 · 0001665988-25-000032 · Items 5.02

  19. 10-Q · Quarterly report

    Report date 2025-09-27 · 0001665988-25-000026

  20. 8-K · Current report

    Report date 2025-11-04 · 0001665988-25-000025 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-06-28 · 0001665988-25-000017

  22. 8-K · Current report

    Report date 2025-08-06 · 0001665988-25-000016 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-07-31 · 0001193125-25-172192 · Items 1.01,2.03,9.01

  24. 8-K · Current report

    Report date 2025-07-30 · 0001665988-25-000013 · Items 8.01,9.01

  25. 8-K · Current report

    Report date 2025-06-03 · 0001665988-25-000010 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-29 · 0001628280-25-022401

  27. 8-K · Current report

    Report date 2025-05-06 · 0001628280-25-022400 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001628280-25-018715

  29. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-011831

  30. 8-K · Current report

    Report date 2025-03-11 · 0001628280-25-011830 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2024-12-31 · 0001628280-25-000253 · Items 2.01,8.01,9.01

  32. SC 13G/A · Ownership disclosure

    0001193125-24-254386

  33. 10-Q · Quarterly report

    Report date 2024-09-28 · 0001628280-24-045114

  34. 8-K · Current report

    Report date 2024-11-05 · 0001628280-24-045112 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2024-09-30 · 0001628280-24-042266 · Items 1.01,8.01,9.01

  36. 10-Q · Quarterly report

    Report date 2024-06-29 · 0001628280-24-034979

  37. 8-K · Current report

    Report date 2024-08-06 · 0001628280-24-034976 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2024-07-19 · 0001193125-24-181655 · Items 8.01

  39. SC 13G/A · Ownership disclosure

    0001193125-24-179104

  40. 8-K · Current report

    Report date 2024-06-19 · 0001193125-24-165735 · Items 1.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001665988Bioventus Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$573.28M$615.76M
    2023-12-31$512.35M$566.52M
    2022-12-31$512.12M$589.51M
    2021-12-31$430.90M$535.71M
    2020-12-31$321.16M$418.11M
    2019-12-31$340.14M$448.26M

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗